Non-medical use of ketamine.

PMCID: PMC1676978 PMID:8461808

Full text

These references are in PubMed. This may not be the complete list of references from this article.

Cotman C. W., Monaghan D. T., Ganong A. H. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu Rev Neurosci. 1988;11:61–80. doi: 10.1146/annurev.ne.11.030188.000425. [DOI] [PubMed] [Google Scholar]
Fine J., Finestone S. C. Sensory disturbances following ketamine anesthesia: recurrent hallucinations. Anesth Analg. 1973 May-Jun;52(3):428–430. [PubMed] [Google Scholar]
Ghoneim M. M., Hinrichs J. V., Mewaldt S. P., Petersen R. C. Ketamine: behavioral effects of subanesthetic doses. J Clin Psychopharmacol. 1985 Apr;5(2):70–77. [PubMed] [Google Scholar]
Jansen K. L. Ketamine--can chronic use impair memory? Int J Addict. 1990 Feb;25(2):133–139. doi: 10.3109/10826089009056204. [DOI] [PubMed] [Google Scholar]
Jansen K. Near death experience and the NMDA receptor. BMJ. 1989 Jun 24;298(6689):1708–1708. doi: 10.1136/bmj.298.6689.1708-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
Perel A., Davidson J. T. Recurrent hallucinations following ketamine. Anaesthesia. 1976 Oct;31(8):1081–1083. doi: 10.1111/j.1365-2044.1976.tb11948.x. [DOI] [PubMed] [Google Scholar]
White P. F., Way W. L., Trevor A. J. Ketamine--its pharmacology and therapeutic uses. Anesthesiology. 1982 Feb;56(2):119–136. doi: 10.1097/00000542-198202000-00007. [DOI] [PubMed] [Google Scholar]